U.S. hospital groups have challenged the Trump administration’s rule that requires them to be more transparent about prices they charge patients for healthcare services, according to a lawsuit filed on Wednesday.
Search
Recent Posts
- Samoa extends measles state of emergency, NZ to fund Pacific vaccination campaign
- Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
- U.S. FDA gives early approval to Sarepta's newest DMD treatment
- Home is now the most common place of death in the U.S.
- U.S. Supreme Court justices lean toward insurers on $12 billion Obamacare claims
- J&J CEO spurns U.S. congressional hearing on carcinogens in talc products
- Health experts warn of emerging threat of Nipah virus
- Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
- Weight-loss surgery between pregnancies tied to better outcomes
- FDA probes diabetes drug metformin for carcinogen NDMA
- Hospital groups file lawsuit to block Trump's price transparency rule
- Malaria fight stalling at 'unacceptably high level' of deaths: WHO
- U.S. considers easing drug protection to break deadlock over trade pact: Wall Street Journal
- Bangladesh plans to ban e-cigarettes amid growing health concerns
- China to use drug bulk-buy program to close price gap
- Drinking-related liver disease and deaths on the rise in U.S.
- Four killed in attacks against Ebola response centers in Congo
- MRI spots tumors in women with dense breasts, but false positives a problem
- U.S. judge partially overturns conviction of opioid maker Insys' founder
- FDA approves Global Blood Therapeutics's sickle cell disease drug